B O O K - American College of Rheumatology

ACR/ARHP Poster Session C
1900. IL-7 Receptor Effector T Cells Are Increased in the Inflamed
Salivary Glands of pSS Patients and Correlate with
Inflammatory Markers. A. Bikker, A. A. Kruize, M. J. G. Wenting,
J. W. J. Bijlsma, F. P. J. G. Lafeber and J. A. G. van Roon,
Rheumatology &Clinical Immunology, University Medical Center
Utrecht, The Netherlands.
1901. Immunization with Ro60 Peptide Leads to Sjögren’s Like
Syndrome in Mice with Appropriate Genetic Background.
Biji T. Kurien 1 , Sima Asfa 3 , Anil D’souza 3 , Yaser Dorri 3 , Skyler P.
Dillon 3 , Sherry Hubbel 3 , Ali W. Khalili 2 , Olga Yeliosof, Yun Jong
Lee, Shannon Maier 3 and R. Hal Scofield 3 , 1 Oklahoma Medical
Research Foundation, 2 University of Oklahoma, 3 University of
Oklahoma Health Sciences Center.
1902. Impaired Gastric Emptying in Primary Sjögren’s Syndrome.
Oskar Hammar, Bodil Ohlsson, Per Wollmer and Thomas Mandl,
Skåne University Hospital Malmö, Malmö, Sweden.
1903. Increased Numbers of IL-7Rα-CD25+FoxP3+ T Cells in pSS
Patients Do Not Prevent Th1 and Th17 Induction by IL-7. A.
Bikker, F. M. Moret, A. A. Kruize, J. W. J. Bijlsma, F. P. J. G. Lafeber
and J. A. G. van Roon, Rheumatology & Clinical Immunology,
University Medical Center Utrecht, The Netherlands.
1904. Interferon Type I Signature in Monocytes in Primary Sjögren’s
Syndrome. Zana Brkic 1 , Cornelia G. van Helden-Meeuwsen 1 ,
Joop van der Merwe 1 , Hemmo A. Drexhage 1 and Marjan A.
Versnel 2 , 1 Dept Immunology, Rotterdam, The Netherlands, 2 Dept
Immunology, Erasmus MC, Rotterdam, The Netherlands.
1905. Is Retreatment with Rituximab in Patients with Primary
Sjögren’s Syndrome Safe and Effective? Petra M. Meiners,
Arjan Vissink, Jiska M. Meijer, Fred K. .L Spijkervet, Cees G. M.
Kallenberg and Hendrika Bootsma, University Medical Center
Groningen, Groningen, The Netherlands.
1906. Molecular and Cellular Evolution of Functional Tertiary
Lymphoid Structures in Salivary Glands of NOD Mice. Elisa
Astorri 3 , Michele Bombardieri 3 , Elisa Corsiero 3 , Francesca
Barone 1 , Gordon Proctor 2 and Costantino Pitzalis 3 , 1 Birmingham
University, Birmingham, United Kingdom, 2 King’s College,
London, London, United Kingdom, 3 Queen Mary University
London, London, United Kingdom.
1907. New Classification Criteria for Childhood Sjögren’s Syndrome.
Naoto Yokogawa 8 , Scott M. Lieberman 1 , Sharon M. Bout-
Tabaku 3 , Faizan Alawi 7 , Juan P. Palazzo 6 , Martha Guttenberg 2 ,
David D. Sherry 5 and Frederick B. Vivino 4 , 1 Children’s Hosp of
Philadelphia, Philadelphia, PA, 2 Children’s Hosp of Philadelphia,
3
Nationwide Children’s Hospital, Columbus, OH, 4 Penn
Presbyt Med Ctr, Philadelphia, PA, 5 The Children’s Hospital of
Philadelphia, Philadelphia, PA, 6 Thomas Jefferson Univ., 7 Univ. of
Pennsylvania, 8 Univ. of Pennsylvania / Tokyo Metropolitan Tama
Medical Center.
1908. New Insights in Sjögren Syndrome Associated Peripheral
Neuropathies: The Small Fibre Neuropathy and Its Clinical,
Immunological and Neurophysiological Features from a
Moncentre Cohort of 24 Patients. Damien Sène 2 , Jean-Pascal
Lefaucheur 1 , Julien Haroche 2 , David Saadoun 2 , Baptiste Hervier 2 ,
Jean-Charles Piette 2 , Zahir Amoura 2 and Patrice Cacoub 2 , 1 Henri-
Mondor Hospital, 2 Pitié-Salpêtrière Hospital.
1909. Novel Lupus Susceptible Gene Polymorphisms in Patients with
Sjögren’s Syndrome in Japanese Population. Tetsuya Horita 1 ,
Hisako Nakagawa 1 , Takashi Kurita 1 , Toshio Odani 1 , Yuichiro
Fujieda 1 , Kotaro Otomo 2 , Masaru Kato 1 , Shinsuke Yasuda 1 ,
Tatsuya Atsumi 1 and Takao Koike 1 , 1 Medicine II, Hokkaido
University, Sapporo, Hokkaido, Japan, 2 Medicine II, Hokkaido
University.
1910. Patients’ Complaints Depend on Systemic Status in Patient
with Primary Sjögren ‘s Syndrome: Concordant Results from
2 Independant Cohorts. Raphaèle Seror 3 , Philippe Ravaud 23 ,
Simon J. Bowman 24 , Hendrika Boostma 25 , Manel Ramos-Casals 17 ,
Elke Theander 18 , Thomas Doerner 1 , Eric Hachulla 20 , Jacques E.
Gottenberg 22 , Athanasios G. Tzioufas 19 , Alain Saraux 7 , Veronique
Le Guern 16 , Stephanie Rist 10 , Claire Larroche 14 , Anne Laure
Fauchais 8 , Aleth Pedriger 12 , Jacques Morel 9 , Jean Sibilia 21 ,
Jean-Jacques Dubost 6 , Olivier Vittecoq 13 , Philippe Dieudé 15 ,
Xavier Puechal 5 , Damien Sene 11 , Charles Zarnitsky 4 , Claudio
Vitali 26 and Xavier Mariette 2 , 1 Berlin Charite University Hospital,
2
Bicetre Hospital/Paris Univ, Le Kremlin Bicetre, France, 3 Bicetre
Hospital/Paris Univ, Le Kremlin Bicetre, France, 4 CH du Havre,
5
CH du Mans, 6 CHU Clermont-Ferrand, 7 CHU de la Cavale
Blanche, Brest Cedex, France, 8 CHU Limoges, 9 CHU Montpellier,
10
CHU Orléans, 11 CHU Pitié Salpetriere, 12 CHU Rennes, 13 CHU
Rouen, 14 Hopital Avicenne, 15 Hopital Bichat, 16 Hopital Cochin,
17
Josep Font Hospital, Barcelona, 18 Malmö University Hospital,
19
Medical School-Univ of Athens, Athens, Greece, 20 National
Scleroderma Centre, Lille Cedex, France, 21 Strasbourg Hospitals,
22
Strasbourg Hospitals, Strasbourg, France, 23 Universite
Paris-Rene Descartes, 24 University Hospital Birmingham NHS
Foundation Trust, 25 University Medical Center Groningen,
26
Villamarina Hospital Pimobino.
1911. Primary Sjögren’s Syndrome-Associated Non Ataxic
Sensory Neuropathies and Sensorimotor Neuropathies Are
Characterized by Distinctive Immunological Profiles. Damien
Sène 2 , Moez Jallouli 2 , Jean-Pascal Lefaucheur 1 , David Saadoun 2 ,
Thierry Maisonobe 2 , Julien Haroche 2 , Marie-Claude Diemert 2 ,
Lucile Musset 2 , Jean-Charles Piette 2 , Zahir Amoura 2 and Patrice
Cacoub 2 , 1 Henri-Mondor Hospital, 2 Pitie-Salpetriére Hospital.
1912. Prognosis of Non-Hodgkin Lymphomas in Primary Sjogren’s
Syndrome. Michael Voulgarelis, Panayiotis D. Ziakas, Aristea
Papageorgiou, Athanasios G. Tzioufas and Haralampos M.
Moutsopoulos, Dept of Pathophysiology, Medical School,
University of Athens, Greece.
1913. Risk of Non-Hodgkin’s Lymphoma in Primary Sjögren’s
Syndrome. Svein J A. Johnsen 3 , Johan G. Brun 1 , Tom B.
Johannesen 2 , Lasse Gøransson 3 , Karstein Haldorsen 1 , Roland
Jonsson 4 and Roald Omdal 3 , 1 Haukeland University Hospital,
2
Norwegian Cancer Registry, 3 Stavanger University Hospital,
4
University of Bergen.
1914. The FMS-Like Tyrosine Kinase3-Ligand (FL) Is a Marker for
Lymphoma in Primary Sjögren’s Syndrome (SS). Jacques-Olivier
Pers 1 , Gabriel J. Tobon 1 , Jacques E. Gottenberg 7 , Raphaèle
Seror 4 , Valérie Devauchelle 2 , Jacques Morel 5 , Stéphanie Rist 6 ,
Alain Saraux 3 and Pierre Youinou 1 , 1 Brest University, Brest,
France, 2 Brest University, 3 CHU de la Cavale Blanche, Brest
Cedex, France, 4 Le Kremlin Bicetre Hospital, 5 Montpellier
University, 6 Orleans Hospital, 7 Strasbourg Hospitals, Strasbourg,
France.
1915. The Role of Immunostaining Against the Panaxonal Protein
PGP 9.5 in the Evaluation of Sjogren’s Sensory Neuropathies,
and the Increased Frequency of Male Sex and Seronegativity
to Anti-La/SS-B Autoantibody with Peripheral Neuropathies.
Julius Birnbaum, Alan N. Baer and Michael Polydefkis, Johns
Hopkins University, Baltimore, MD.
1916. The Temporal Appearance of Symptoms and Signs in Primary
Sjögren’s Syndrome. Chiara Baldini, Nicoletta Luciano, Pasquale
Pepe, Rosaria Talarico, Sara Grossi, Antonio Gaetano Tavoni
and Stefano Bombardieri, Rheumatology Unit, Department of
Internal Medicine, University of Pisa, Italy.
2010 Program Book 267